# Facial Skin Care Instruction by Medical Professionals Using Microneedle Cream: The 8‐Week Prospective, Randomized, Single‐Blinded for Examiners Trial in Asians

**Authors:** Toko Mori, Yurika Osuji, Ruriko Kawanabe, Takemichi Fukasawa, Jun Omatsu, Asako Yoshizaki, Takashi Yamashita

PMC · DOI: 10.1111/jocd.70680 · Journal of Cosmetic Dermatology · 2026-02-02

## TL;DR

This study shows that structured skin care instruction improves the effectiveness of microneedle cream on skin hydration, elasticity, and pigmentation in Asian women over 8 weeks.

## Contribution

The study is the first to demonstrate the impact of early skin care instruction on microneedle cream efficacy through objective and subjective measures.

## Key findings

- The intervention group showed significantly better skin hydration and elasticity at week 4 compared to the control group.
- By week 8, the intervention group had significantly reduced melanin pigmentation compared to the control group.
- Subjective assessments aligned with objective improvements, indicating better perceived skin quality in the intervention group.

## Abstract

Skin care is widely regarded as a fundamental component of self‐care. However, few studies have systematically evaluated the effects of structured skin care instruction on both objective parameters and subjective perceptions. This study aims to elucidate these effects through a controlled clinical investigation.

This clinical trial was conducted at the University of Tokyo Hospital between July and September 2023. Twenty‐one healthy women aged 30–60 years applied a microneedle cream to the face for 8 weeks. They were randomly assigned to either the intervention group, which received skin care instructions from the start, or the control group, which received them after 4 weeks. Skin hydration, transepidermal water loss, viscoelasticity, and melanin content were assessed at baseline, week 4, and week 8. Subjective evaluations were obtained via structured questionnaires. Statistical analyses were conducted using Prism (version 10.2.3).

At week 4, the intervention group showed significantly greater improvements in skin hydration (intracorneal water content: −0.98% ± 13.49% [control] vs. 14.06% ± 14.61% [intervention], p < 0.05) and elasticity (R7: −3.48% ± 10.36% [control] vs. 7.92% ± 10.29% [intervention], p < 0.05) compared to the control group. At week 8, melanin pigmentation was significantly reduced in the intervention group (Mark‐Vu: 11.44% ± 26.67% [control] vs. −15.01% ± 11.10% [intervention], p < 0.05). Subjective assessments were consistent with these objective results, reflecting improved skin perception.

This is the first study to demonstrate that appropriate skin care practices can lead to the moisturizing, firming, and elasticity effects of a microneedle cream. These findings highlight the importance of proper product use in maximizing the efficacy of skin care interventions.

UMIN: UMIN000052080

## Full-text entities

- **Genes:** HSPB6 (heat shock protein family B (small) member 6) [NCBI Gene 126393] {aka HEL55, Hsp20, PPP1R91}, COL3A1 (collagen type III alpha 1 chain) [NCBI Gene 1281] {aka EDS4A, EDSVASC, PMGEDSV}, COL8A1 (collagen type VIII alpha 1 chain) [NCBI Gene 1295] {aka C3orf7}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, KRT13 (keratin 13) [NCBI Gene 3860] {aka CK13, K13, WSN2}, TGFB3 (transforming growth factor beta 3) [NCBI Gene 7043] {aka ARVD, ARVD1, LDS5, RNHF, TGF-beta3}, TIMP3 (TIMP metallopeptidase inhibitor 3) [NCBI Gene 7078] {aka HSMRK222, K222, K222TA2, SFD}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}, CCL11 (C-C motif chemokine ligand 11) [NCBI Gene 6356] {aka SCYA11}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}
- **Diseases:** rosacea (MESH:D012393), atopic dermatitis (MESH:D003876), hyperpigmentation (MESH:D017495), TEWL (MESH:D000069578), edema (MESH:D004487), stinging (MESH:D001733), hypersensitivity (MESH:D004342), dermatoses (MESH:D012871), contact dermatitis (MESH:D003877), itching (MESH:D011537), urticaria (MESH:D014581), inflammation (MESH:D007249), skin cancer (MESH:D012878), Erythema (MESH:D004890), irritation (MESH:D001523), dry skin (MESH:D015352), acne (MESH:D000152), malignancy (MESH:D009369), pigmentation (MESH:D010859), melasma (MESH:D008548), dryness (MESH:D014987)
- **Chemicals:** porphyrins (MESH:D011166), sodium hyaluronate (MESH:D006820), mannan (MESH:D008351), water (MESH:D014867), chitosan (MESH:D048271), Niacinamide (MESH:D009536), MX18 (-), Centella asiatica  extract (MESH:C526146), Melanin (MESH:D008543), silicone (MESH:D012828), hydroxypropyl (MESH:D065347)
- **Species:** Homo sapiens (human, species) [taxon 9606], Lactobacillus (genus) [taxon 1578], Malpighia emarginata (species) [taxon 151847]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12865263/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12865263/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12865263/full.md

---
Source: https://tomesphere.com/paper/PMC12865263